Warfarin anti-coagulation control in patients taking proton pump inhibitors

被引：0
|
作者：
Donnellan, CF
Dass, S
Dunn, F
Hull, MA
机构：
[1] St James Univ Hosp, Dept Gastroenterol, Leeds LS9 7TF, W Yorkshire, England
[2] Seacroft Hosp, Anticoagulat Clin, Leeds, W Yorkshire, England
来源：
GUT | 2002年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
237
引用
收藏
页码：A65 / A66
页数：2
相关论文
共 50 条
  • [21] Proton pump inhibitors co-prescribed with warfarin reduce warfarin control as measured by time in therapeutic range
    Bertram, Victoria
    Yeo, Kelly
    Anoopkumar-Dukie, Shailendra
    Bernaitis, Nijole
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2019, 73 (11)
  • [22] Safflower yellow for injection enhances anti-coagulation of warfarin in rats: implications in pharmacodynamics and pharmacokinetics
    Liu, Yan
    Sun, Jiahui
    Yang, Chunjuan
    Qin, Mengnan
    Xu, Shiwei
    Zhao, Yue
    Liu, Gaofeng
    XENOBIOTICA, 2024, 54 (02) : 75 - 82
  • [23] Low yield of endoscopy in patients with persistent dyspepsia taking proton pump inhibitors
    Smith, T
    Verzola, E
    Mertz, H
    GASTROINTESTINAL ENDOSCOPY, 2003, 58 (01) : 9 - 13
  • [24] Infection risk and management strategies for patients with cirrhosis taking proton pump inhibitors
    Zerr, Beth
    Vazquez, Alejandro
    Erstad, Brian L.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2023, 80 (15) : 967 - 973
  • [25] Risk of fall in patients taking proton pump inhibitors: a meta-analysis
    Lapumnuaypol, K.
    Thongprayoon, C.
    Wijarnpreecha, K.
    Tiu, A.
    Cheungpasitporn, W.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2019, 112 (02) : 115 - 121
  • [26] Mechanisms contributing to increased cardiovascular risk in patients taking proton pump inhibitors
    Amaral, J. H.
    Tanus-Santos, J. E.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2017, 29 (02):
  • [27] PROTON PUMP INHIBITORS AND WARFARIN: ANY REASON FOR CAREFUL MONITORING?
    Segato, S.
    Daverio, F.
    Parravicini, M.
    Cortelezzi, C. C.
    Millefanti, L.
    Ageno, W.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E80 - E81
  • [28] CONTRAINDICATIONS TO ANTI-COAGULATION AND THE DECISION TO INITIATE WARFARIN THERAPY IN NON-VALVULAR ATRIAL FIBRILLATION
    Ewen, E.
    Elliott, D. J.
    Simon, T. A.
    Jackson, J.
    Weintraub, W. S.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 : 48 - 48
  • [29] Effect of proton pump inhibitors on glycemic control in patients with diabetes
    Takebayashi, Kohzo
    Inukai, Toshihiko
    WORLD JOURNAL OF DIABETES, 2015, 6 (10): : 1122 - 1131
  • [30] The effect of proton pump inhibitors on glycaemic control in diabetic patients
    Rajput, Muhammad Ali
    Ali, Fizzah
    Zehra, Tabassum
    Zafar, Shahid
    Kumar, Gunesh
    JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES, 2020, 15 (03): : 218 - 223
12345